The Dynamics of Human Cytomegalovirus Replication in Vivo
暂无分享,去创建一个
Vincent C. Emery | Paul D. Griffiths | P. Griffiths | V. Emery | Dehila Gor | Alethea V. Cope | E. Frances Bowen | A. Cope | E. Bowen | D. Gor
[1] J. Cherrington,et al. Clinical uses of cidofovir , 1997, Reviews in medical virology.
[2] P. Griffiths,et al. Use of the polymerase chain reaction to analyse sequence variation within a major neutralizing epitope of glycoprotein B (gp58) in clinical isolates of human cytomegalovirus. , 1991, The Journal of general virology.
[3] M. Miller,et al. Molecular epidemiology of cytomegalovirus infections associated with bone marrow transplantation. , 1985, Annals of internal medicine.
[4] C. Sabin,et al. Quantity of cytomegalovirus viruria is a major risk factor for cytomegalovirus disease after renal transplantation , 1997, Journal of medical virology.
[5] S. Riddell,et al. T cell therapy of human CMV and EBV infection in immunocompromised hosts , 1997, Reviews in medical virology.
[6] M A Nowak,et al. Human immunodeficiency virus drug therapy and virus load , 1997, Journal of virology.
[7] M A Nowak,et al. Virus dynamics and drug therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[8] J. Walker-Smith,et al. SMALL-INTESTINAL HISTOLOGY IN CŒLIAC DISEASE , 1975, The Lancet.
[9] Angela R. McLean,et al. Zidovudine and HIV: Mathematical models of within‐host population dynamics , 1995 .
[10] S. Spector,et al. Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients. , 1998, The Journal of clinical investigation.
[11] M A Nowak,et al. Pre-existence and emergence of drug resistance in HIV-1 infection. , 1997, Proceedings. Biological sciences.
[12] C. Crumpacker. Drug therapy : Ganciclovir , 1996 .
[13] C. Sabin,et al. Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease , 1998, Bone Marrow Transplantation.
[14] A. Perelson,et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.
[15] C. Sabin,et al. The effect of valaciclovir on cytomegalovirus viremia and viruria detected by polymerase chain reaction in patients with advanced human immunodeficiency virus disease. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group. , 1998, The Journal of infectious diseases.
[16] C. Sabin,et al. Cytomegalovirus retinitis in AIDS patients: influence of cytomegaloviral load on response to ganciclovir, time to recurrence and survival , 1996, AIDS.
[17] M A Nowak,et al. Viral dynamics in hepatitis B virus infection. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[18] Alan S. Perelson,et al. Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy , 1998 .
[19] S. Chou,et al. Reactivation and recombination of multiple cytomegalovirus strains from individual organ donors. , 1989, The Journal of infectious diseases.
[20] Martin A. Nowak,et al. Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.
[21] C. Sabin,et al. Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV‐positive patients at high risk of CMV disease , 1997, AIDS.
[22] A S Perelson,et al. Human immunodeficiency virus fitness in vivo: calculations based on a single zidovudine resistance mutation at codon 215 of reverse transcriptase , 1996, Journal of virology.
[23] Wilmot. THE CHARTER OF THE ROYAL COLLEGE OF SURGEONS IN LONDON. , 1824 .
[24] K. Fish,et al. Reactivation of Latent Human Cytomegalovirus by Allogeneic Stimulation of Blood Cells from Healthy Donors , 1997, Cell.
[25] C. Sabin,et al. Interrelationships among quantity of human cytomegalovirus (HCMV) DNA in blood, donor-recipient serostatus, and administration of methylprednisolone as risk factors for HCMV disease following liver transplantation. , 1997, The Journal of infectious diseases.
[26] P. Griffiths,et al. Development of a point mutation assay for the detection of human cytomegalovirus UL97 mutations associated with ganciclovir resistance. , 1997, Journal of virological methods.
[27] S. Chou,et al. Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates. , 1995, The Journal of infectious diseases.
[28] D. Pillay. Book review. Antiviral Drug Resistance Ed. by Douglas D. Richman, John Wiley & Sons, Chichester, 1996. , 1998 .
[29] 藤井 良知. Cytomegalovirus , 1966, Definitions.
[30] P. Griffiths,et al. Quantification of human cytomegalovirus DNA using the polymerase chain reaction. , 1992, The Journal of general virology.
[31] P. Griffiths,et al. SYMPTOMATIC CYTOMEGALOVIRUS INFECTION IN SEROPOSITIVE KIDNEY RECIPIENTS: REINFECTION WITH DONOR VIRUS RATHER THAN REACTIVATION OF RECIPIENT VIRUS , 1988, The Lancet.
[32] C. Sabin,et al. Cytomegalovirus polymerase chain reaction viraemia in patients receiving ganciclovir maintenance therapy for retinitis , 1998, AIDS.